reports
- Bruno Cavalier
- Luis de Toledo Heras
- Thomas Zlowodzki
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
UTDI UNITED INTERNET AG
EL ESSILORLUXOTTICA SA
PHA PHARMAGEST INTERACTIVE SA
FAGR FAGRON SA
BRBY BURBERRY GROUP PLC
KER KERING SA
BOSS HUGO BOSS AG
NANO NANOBIOTIX SA
01913 PRADA S.P.A.
AIXA AIXTRON SE
MLP MLP SE
PAT PATRIZIA AG
MONC MONCLER SPA
ENG ENAGAS SA
SMHN SUESS MICROTEC AG
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
TCH TECHNICOLOR SA
ZGN ERMENEGILDO ZEGNA NV
CTPNV CTP NV
DIA DISTRIBUIDORA INTERNACIONAL DE ALIMENTACION SA
- Bruno Cavalier
- Luis de Toledo Heras
- Thomas Zlowodzki
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
UTDI UNITED INTERNET AG
EL ESSILORLUXOTTICA SA
PHA PHARMAGEST INTERACTIVE SA
FAGR FAGRON SA
BRBY BURBERRY GROUP PLC
VETO VETOQUINOL SA
KER KERING SA
BOSS HUGO BOSS AG
NANO NANOBIOTIX SA
01913 PRADA S.P.A.
AIXA AIXTRON SE
MLP MLP SE
PAT PATRIZIA AG
MONC MONCLER SPA
ENG ENAGAS SA
SMHN SUESS MICROTEC AG
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
TCH TECHNICOLOR SA
ZGN ERMENEGILDO ZEGNA NV
DIA DISTRIBUIDORA INTERNACIONAL DE ALIMENTACION SA
- Robert Jan Vos
- Usama Tariq
- Jerôme Bodin
APAML APERAM SA
ZIL2 ELRINGKLINGER AG
HCO HIGHCO SA
CGM CEGEDIM SA
PSM PROSIEBENSAT.1 MEDIA SE
VETO VETOQUINOL SA
LNA LNA SANTE SA
CAI CA IMMOBILIEN ANLAGEN AG
CWC CEWE STIFTUNG & CO KGAA
UBS UBM DEVELOPMENT AG
SLIGR SLIGRO FOOD GROUP N.V.
ONTEX ONTEX GROUP N.V.
DGM DIAGNOSTIC MEDICAL SYSTEMS
WPL WIRTUALNA POLSKA HOLDING SA
JUN3 JUNGHEINRICH AG PREF
JST JOST WERKE AG
2CRSI 2CRSI SA
S92 SMA SOLAR TECHNOLOGY AG
MRX MISTER SPEX SE
FLE PEGASUS ENTREPRENEURIAL ACQUISITION CO EURO BV
AROBS AROBS TRANSILVANIA SOFTWARE SA
FLOW FLOW TRADERS LTD
IOS IONOS GROUP SE
ARVEN ARVERNE GROUP SA
- Jerôme Bodin
APAML APERAM SA
ZIL2 ELRINGKLINGER AG
HCO HIGHCO SA
CGM CEGEDIM SA
PSM PROSIEBENSAT.1 MEDIA SE
VETO VETOQUINOL SA
LNA LNA SANTE SA
CAI CA IMMOBILIEN ANLAGEN AG
CWC CEWE STIFTUNG & CO KGAA
UBS UBM DEVELOPMENT AG
SLIGR SLIGRO FOOD GROUP N.V.
ONTEX ONTEX GROUP N.V.
DGM DIAGNOSTIC MEDICAL SYSTEMS
WPL WIRTUALNA POLSKA HOLDING SA
JUN3 JUNGHEINRICH AG PREF
JST JOST WERKE AG
2CRSI 2CRSI SA
S92 SMA SOLAR TECHNOLOGY AG
MRX MISTER SPEX SE
FLE PEGASUS ENTREPRENEURIAL ACQUISITION CO EURO BV
AROBS AROBS TRANSILVANIA SOFTWARE SA
FLOW FLOW TRADERS LTD
IOS IONOS GROUP SE
ARVEN ARVERNE GROUP SA
- Julian Dobrovolschi
- ING Helpdesk
Benelux Morning Notes
AEGON: merger of Corebridge and Equitable, implications for Transamerica. Flow Traders: Equity strong as crypto fades. IBA: Net debt above, FY26 REBIT guidance on the low side, 2H25 REBIT a bit below. Sofina: Final NAV 2% above preliminary results. Zabka: Peer Dino Polska FY25 results
Galapagos kondigt de voordracht aan van Gino Santini tot lid van de Ra...
Galapagos kondigt de voordracht aan van Gino Santini tot lid van de Raad van Bestuur De Raad van Bestuur is voornemens de heer Santini te benoemen tot Voorzitter, als opvolger van Jérôme Contamine, onder voorbehoud van zijn benoeming door aandeelhouders De heer Santini zal uitgebreide ervaring op het gebied van corporate governance, bedrijfsontwikkeling en leiderschap in de sector toevoegen aan de Raad van Bestuur Mechelen, België; 26 maart, 2026, 21:02 CET — Galapagos NV (Euronext & NASDAQ: GLPG), heeft vandaag bekendgemaakt dat Gino Santini is voorgedragen als Niet-Uitvoerend Onafhankel...
Galapagos Announces Nomination of Gino Santini to its Board of Directo...
Galapagos Announces Nomination of Gino Santini to its Board of Directors Subject to his election by shareholders, the Board intends to appoint Mr. Santini as Chair, succeeding Jérôme Contamine Mr. Santini will bring extensive corporate governance, business development and industry leadership experience to the Board Mechelen, Belgium; March 26, 2026, 21:02 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced the proposed appointment of Gino Santini as a Non-Executive Independent Director, with the intention to appoint him as Chair of its Board of Directors, subject to shareholder...
Galapagos Publishes 2025 Annual Report and Announces Annual and Extrao...
Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings Mechelen, Belgium; March 26, 2026, 21:01 CET; regulated information — Galapagos NV (Euronext & NASDAQ: GLPG) today published its annual report for the financial year 2025 and announced that its Annual Shareholders’ Meeting (AGM) and an Extraordinary Shareholders' Meeting (EGM) will be held sequentially on Tuesday, April 28, 2026 at 14:00 CET and 15:00 CET at Schaliënhoevedreef 20T, 2800 Mechelen, Belgium. The annual report for the financial year 2025, including a review of figures and perfo...
Galapagos publiceert 2025 jaarverslag en kondigt de Gewone (jaarlijkse...
Galapagos publiceert 2025 jaarverslag en kondigt de Gewone (jaarlijkse) en Buitengewone Algemene Vergaderingen aan Mechelen, België; 26 maart, 2026, 21:01 CET; gereglementeerde informatie — Galapagos NV (Euronext & NASDAQ: GLPG) heeft vandaag haar jaarverslag over het boekjaar 2025 gepubliceerd en aangekondigd dat haar Gewone (jaarlijkse) Algemene Vergadering (GAV) en een Buitengewone Algemene Vergadering (BAV) achtereenvolgens zullen plaatsvinden op dinsdag 28 april 2026 om 14.00 uur en 15.00 uur te Schaliënhoevedreef 20T, 2800 Mechelen, België. Het jaarverslag over het boekjaar 2025, inc...
Aegon publishes Integrated Annual Report 2025
Aegon publishes Integrated Annual Report 2025 Schiphol, March 26, 2026 - Aegon today publishes its Integrated Annual Report 2025. The report provides an overview of the company’s businesses, strategy and approach to sustainability, as well as its financial and non-financial performance over the past year. The report also reflects on the decisions and events that shaped the year, the developments influencing Aegon’s markets and stakeholders, and how the company continues to create and share long-term value. The Integrated Annual Report 2025 is available on aegon.com and can be downloaded . ...
Aegon nominates Marco Keim to succeed Lard Friese on the Supervisory B...
Aegon nominates Marco Keim to succeed Lard Friese on the Supervisory Board of a.s.r. Schiphol, March 25, 2026 - Aegon has nominated Marco Keim, CEO of Aegon’s International business and a member of the Executive Committee, to succeed Aegon CEO, Lard Friese, as a non-independent member of the Supervisory Board of Dutch insurer, a.s.r., in which Aegon holds a strategic stake of approximately 24%. The nomination follows on December 10, 2025, that Mr. Friese would step down as a non-independent member of a.s.r.’s Supervisory Board to focus on the relocation of Aegon’s head office and legal sea...
- Elias New
- Nicolas David
- Sinan Doganli
- Elias New
- Nicolas David
- Sinan Doganli
- Jacob Mekhael
Galapagos Advanced discussions with Gilead on potential collaboration
Galapagos announced that, following Gilead entering into a definitive agreement to acquire Ouro Medicines for $1,675m in cash consideration, and up to $500m in contingent milestone payments, Galapagos and Gilead are in advanced partnership discussions. Economically, Galapagos would effectively co-finance Gilead's acquisition and early-stage development of gamgertamig in return for royalties on net sales (20-23%) and freedom to go up to $500m (previously $150m) in the amended OLCA. In our view, t...
- Guy Sips
- Jacob Mekhael
- Livio Luyten
- Wim Hoste
- Martial Descoutures
- Martial Descoutures
Galapagos and Gilead in Advanced Discussions to Collaborate on Advanci...
Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases Galapagos intends to enter into a strategic collaboration with Gilead following Gilead's acquisition of Ouro Medicines New partnership structure would achieve meaningfully improved financial terms and flexibility for Galapagos Following this potential transaction, the Company will continue to have a majority of its capital available for additional strategic transactions and other capital allocation priorities Mechelen, Belgium; March 23, 2026, 23:02 CE...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.